Andere Sprachen Diagonal Bio AB

Aktien

A3CR6X

SE0015961826

DIABIO

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 17:23:34 26.04.2024			% 5 Tage	% 1. Jan.
0.0752 ^SEK	-5.41%		-13.96%	-78.70%

05.04.	Diagonal Bio AB (Publ) gibt die Verlängerung der Partnerschaft mit der Tierklinik Horsholm bekannt	CI
05.04.	Diagonal Bio AB (Publ) gibt erfolgreiche Ergebnisse der Pilotstudie bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Diagonal Bio AB announces outcome of rights issue	24.04.
Diagonal Bio AB publish - White paper	16.04.
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand	10.04.
The subscription period in Diagonal Bio AB rights issue commences today	08.04.
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic	05.04.
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic	05.04.
Diagonal Bio AB Announces Successful Pilot Study Results	05.04.
Diagonal Bio AB publishes a prospectus because of upcoming rights issue	03.04.
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB	02.04.
Diagonal Bio Makes Interim CEO Permanent	29.02.
Diagonal Bio appoints Karin Wehlin as new CEO	28.02.
Diagonal Bio Appoints Karin Wehlin as New CEO	28.02.
Notice to attend the extraordinary general meeting of Diagonal Bio AB	28.02.
The Board of Directors decides on a preferential rights issue of units in order to finance future development	28.02.
Diagonal Bio AB Year-end Report 2023	28.02.
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
Diagonal Bio Signs Product Distribution Deal With Techtum Lab	16.02.
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31.10.23
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22.08.23
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding	22.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Diagonal Bio AB

Aktien

A3CR6X

SE0015961826

DIABIO

Andere Sprachen

Filter